Evaluation of the osteogenic and chondrogenic differentiation capacities of equine adipose tissue-derived mesenchymal stem cells

American Journal of Veterinary Research

Volumn 71, Issue 10, 2010, Pages 1228-1236

  Braun, Julian ^a   Hack, Anita ^a   Weis Klemm, Michaela ^a   Conrad, Sabine ^b   Treml, Sabrina ^a   Kohler, Konrad ^a   Walliser, Ulrich ^c   Skutella, Thomas ^a,b   Aicher, Wilhelm K ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Horse Clinic Walliser   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; AGGRECAN; ALCIAN BLUE; ALIZARIN RED S; BOVINE SERUM ALBUMIN; CD14 ANTIGEN; CD164 ANTIGEN; COLLAGEN TYPE 2; ENDOGLIN; MEMBRANE ANTIGEN; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; THY 1 ANTIGEN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE INJURY; CARTILAGE CELL; CELL AGING; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLOGY; FLOW CYTOMETRY; HORSE; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERE; TISSUE DIFFERENTIATION;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD; BONE AND BONES; CARTILAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HORSES; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; OSTEOGENESIS; TELOMERE;

ANIMALIA; BOVINAE; EQUIDAE; ORYCTOLAGUS CUNICULUS;

EID: 77958607412     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.71.10.1228     Document Type: Article

References (29)

1. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
2. Chamberlain G, Fox J, Ashton B, et al. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007;25:2739-2749.
3. Vidal MA, Kilroy GE, Johnson JR, et al. Cell growth characteristics and differentiation frequency of adherent equine bone marrow-derived mesenchymal stromal cells: adipogenic and osteogenic capacity. Vet Surg 2006;35:601-610.
4. Worster AA, Nixon AJ, Brower-Toland BD, et al. Effect of transforming growth factor β1 on chondrogenic differentiation of cultured equine mesenchymal stem cells. Am J Vet Res 2000;61:1003-1010.
5. Kisiday JD, Kopesky PW, Evans CH, et al. Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. J Orthop Res 2008;26:322-331.
6. Reed SA, Johnson SE. Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types. J Cell Physiol 2008;215:329-336.
7. Vidal MA, Kilroy GE, Lopez MJ, et al. Characterization of equine adipose tissue-derived stromal cells: adipogenic and osteogenic capacity and comparison with bone marrow-derived mesenchymal stromal cells. Vet Surg 2007;36:613-622.
8. Giovannini S, Brehm W, Mainil-Varlet P, et al. Multilineage differentiation potential of equine blood-derived fibroblast-like cells. Differentiation 2008;76:118-129.
9. Koerner J, Nesic D, Romero JD, et al. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells. Stem Cells 2006;24:1613-1619.
10. Koch TG, Heerkens T, Thomsen PD, et al. Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol 2007;7:26.
11. Wilke MM, Nydam DV, Nixon AJ. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 2007;25:913-925.
12. Pridie A. The method of resurfacing osteoarthritic joints. J Bone Joint Surg Br 1959;41:618-623.
13. Guthrie M. Win, place, or cell. Can a company harness stem cells to treat injured horses? The Scientist 2008;22:75.
14. Siddappa R, Licht R, van Blitterswijk C, et al. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 2007;25:1029-1041. (Pubitemid 47233079)
15. Felka T, Schäfer R, Schewe B, et al. Hypoxia reduced the inhibitory effect of IL-1β on chondrogenic differentiation of FCS-free expanded MSC. Osteoarthritis Cartilage 2009;17:1368-1376.
16. Herzenberg LA, Tung J, Moore WA, et al. Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol 2006;7:681-685.
17. Alexander D, Judex M, Meyringer R, et al. Transcription factor Egr-1 activates collagen expression in immortalized fibroblasts or fibrosarcoma cells. Biol Chem 2002;383:1845-1853.
18. Arnhold SJ, Goletz I, Klein H, et al. Isolation and characterization of bone marrow-derived equine mesenchymal stem cells. Am J Vet Res 2007;68:1095-1105.
19. Vidal MA, Robinson SO, Lopez MJ, et al. Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow. Vet Surg 2008;37:713-724.
20. Li H, Fan X, Kovi RC, et al. Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res 2007;67:10889-10898.
21. Bonab MM, Alimoghaddam K, Talebian F, et al. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 2006;7:14.
22. Budiansky S. The nature of horses: exploring equine evolution, intelligence, and behaviour. New York: The Free Press, 1997.
23. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008;132:631-644.
24. McDuffee LA, Anderson GI, Wright GM, et al. In vitro heterogeneity of osteogenic cell populations at various equine skeletal sites. Can J Vet Res 2006;70:277-284.
25. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113:1161-1166.
26. McIntosh K, Zvonic S, Garrett S, et al. The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 2006;24:1246-1253.
27. Romagnani P, Annunziato F, Liotta F, et al. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 2005;97:314-322.
28. Seta N, Kuwana M. Human circulating monocytes as multipotential progenitors. Keio J Med 2007;56:41-47.
29. Bühring HJ, Battula VL, Treml S, et al. Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci 2007;1106:262-271.